Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR6828ApriorityCriticalpatent/CR6828A/en
Publication of CR6828ApublicationCriticalpatent/CR6828A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invencion se refiere a composiciones farmaceuticas que contienen S-metil-dihidro-ziprasidona y al uso de dicho compuesto y de sus sales farmaceuticamente aceptables para el tratamiento de trastornos psiquiatricos y oculares.This invention relates to pharmaceutical compositions containing S-methyl-dihydro-ziprasidone and the use of said compound and its pharmaceutically acceptable salts for the treatment of psychiatric and ocular disorders.
CR6828A2002-11-222002-11-22
S-METHYL-DIHIDRO-ZIPRASIDONE FOR THE TREATMENT OF PSYCHIATRIC AND EYE DISORDERS
CR6828A
(en)
DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND METHODS FOR USE
SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.
DERIVATIVES OF 2, 6-QUINOLINILO, A PHARMACEUTICAL PREPARATION THAT CONTAINS THEM AND ITS EMPLOYMENT IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF DEPENDENT DISEASES OF INTEGRINES ALFA4BETA1 AND / OR ALFA4BETA7